|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Author(s)Michael Mitchell
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Advertisement
Articles in this issue
almost 23 years ago
A Stress Testing Benchmarking Studyalmost 23 years ago
Cleanroom Pressurization Methodologyalmost 23 years ago
Manufacturing Capability Key to Global Health Advancesalmost 23 years ago
February 2003almost 23 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
